Well I guess if you had been listening to his CC w
Post# of 30028
I am just saying that a couple months have gone by and I would like an update on those kinds of conversations. Surely they have been "soft selling" pharmas doing AD trials and have some idea how those conversations are going! He doesn't need to give "quantitative revenue guidance," just throw us some kind of bone that AD pharma is impressed with what they've seen in LymPro.
Right now everything hinges on how well pharma's view Lympro and whether they're ready to start signing up.
We would trade above .10 cents immediately if Gerald had the where with all to craft such a Press Release. Hell, even I could do it!